1. Home
  2. COR vs RACE Comparison

COR vs RACE Comparison

Compare COR & RACE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cencora Inc.

COR

Cencora Inc.

HOLD

Current Price

$295.44

Market Cap

68.5B

Sector

Health Care

ML Signal

HOLD

Logo Ferrari N.V.

RACE

Ferrari N.V.

HOLD

Current Price

$384.91

Market Cap

61.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
COR
RACE
Founded
2001
1947
Country
United States
Italy
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
68.5B
61.4B
IPO Year
2001
2015

Fundamental Metrics

Financial Performance
Metric
COR
RACE
Price
$295.44
$384.91
Analyst Decision
Buy
Strong Buy
Analyst Count
14
9
Target Price
$390.62
$477.86
AVG Volume (30 Days)
1.4M
506.9K
Earning Date
05-06-2026
05-05-2026
Dividend Yield
0.77%
1.26%
EPS Growth
5.71
N/A
EPS
11.27
N/A
Revenue
$321,332,819,000.00
N/A
Revenue This Year
$8.89
$7.91
Revenue Next Year
$6.75
$7.51
P/E Ratio
$26.30
$34.59
Revenue Growth
9.31
N/A
52 Week Low
$244.82
$312.51
52 Week High
$377.54
$519.10

Technical Indicators

Market Signals
Indicator
COR
RACE
Relative Strength Index (RSI) 65.95 64.83
Support Level $296.08 $380.24
Resistance Level $326.95 $396.73
Average True Range (ATR) 7.18 8.04
MACD 1.98 2.53
Stochastic Oscillator 98.84 98.77

Price Performance

Historical Comparison
COR
RACE

About COR Cencora Inc.

Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.

About RACE Ferrari N.V.

Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2025, the company sold 13,640 vehicles at an average price over EUR 520,000 with more than 80% of its vehicles being sold to existing Ferrari clients. Eighty-four percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2025, the Europe, Middle East, and Africa region accounted for 49% of revenue, the Americas was 32%, mainland China, Hong Kong, and Taiwan was 7%, and the rest of Asia was 12%.

Share on Social Networks: